Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell cycle regulation in diabetic nephropathy.

G Wolf1

  • 1Department of Medicine, University of Hamburg, Germany. wolf@uke.uni-hamburg.de

Kidney International. Supplement
|September 21, 2000
PubMed
Summary

Diabetic nephropathy involves cell cycle arrest in kidney cells, driven by high glucose and other factors. Inhibiting cell cycle regulators may offer new therapeutic strategies for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities.

The Journal of biological chemistry·1995
Same author

L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.

Journal of medicinal chemistry·1995
Same author

[In vitro studies of the effect of vasoconstrictor nose drops on ciliary epithelium of human nasal mucosa].

Laryngo- rhino- otologie·1995
Same author

Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects.

Transplantation·1995
Same author

Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine.

The Journal of biological chemistry·1995
Same author

A regulatory pathway of thermogenesis in brown fat through retinoic acid.

Nutrition reviews·1995

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Biology

Background:

  • Diabetic nephropathy is characterized by early renal hypertrophy.
  • Most renal cells, like mesangial cells, arrest in the G1-phase of the cell cycle.
  • Factors such as high glucose, TGF-beta, and angiotensin II induce cell cycle inhibitors.

Purpose of the Study:

  • To investigate the role of cell cycle regulation in diabetic nephropathy.
  • To explore potential therapeutic targets for preventing diabetic kidney disease progression.

Main Methods:

  • Analysis of cell cycle regulation in diabetic nephropathy models.
  • Investigating the effects of high glucose, TGF-beta, and angiotensin II on cell cycle inhibitors (e.g., p21Cip1, p27KiP1).
  • Evaluating the impact of angiotensin-converting enzyme inhibitors on cell cycle arrest in diabetic rats and the role of p21CiP1 in diabetic mice.

Main Results:

  • High glucose, TGF-beta, and angiotensin II induce cyclin-dependent kinase (CDK) inhibitors, leading to G1-phase cell cycle arrest.
  • CDK inhibitors inactivate G1-phase cyclin/CDK complexes, preventing G1-S phase transition.
  • Angiotensin-converting enzyme inhibitors reduced glomerular hypertrophy and CDK-inhibitor expression in diabetic rats.
  • Diabetic p21CiP1 knockout mice did not develop glomerular hypertrophy or proteinuria.

Conclusions:

  • Cell cycle arrest, mediated by CDK inhibitors, is a key feature of diabetic nephropathy.
  • Therapeutic strategies targeting cell cycle regulation, such as using ACE inhibitors or modulating p21CiP1, show promise in preventing or treating diabetic kidney disease.
  • Understanding cell cycle alterations is crucial for developing novel treatments to prevent irreversible kidney damage.

Related Experiment Videos